Regression of low-grade squamous intra-epithelial lesions in young women

Lancet

Volumn 364, Issue 9446, 2004, Pages 1678-1683

  Moscicki, Anna Barbara ^a,c   Shiboski, Stephen ^a   Hills, Nancy K ^a   Powell, Kimberly J ^a   Jay, Naomi ^a   Hanson, Evelyn N ^a   Miller, Susanna ^a   Canjura Clayton, K Lisa ^a   Farhat, Sepidah ^a   Broering, Jeanette M ^a   Darragh, Teresa M ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c USA ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BIOPSY; BIOSAFETY; CANCER GRADING; CANCER REGRESSION; CIGARETTE SMOKING; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTRACEPTION; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; LONGITUDINAL STUDY; LOW GRADE SQUAMOUS INTRAEPITHELIAL LESION; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PATIENT SELECTION; PRIORITY JOURNAL; PROBABILITY; RISK FACTOR; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; UTERINE CERVIX CANCER; VIRUS INFECTION; WART VIRUS;

EID: 7644221218     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(04)17354-6     Document Type: Article

References (28)

1. Moscicki AB, Shiboski S, Broering J, et al. The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women. J Pediatr. 132:1998;277-284
2. Evander M, Edlund K, Gustafsson A, et al. Human papillomavirus infection is transient in young women: a population-based cohort study. J Infect Dis. 171:1995;1026-1030
3. Ho GY, Burk RD, Klein S, et al. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst. 87:1995;1365-1371
4. Moscicki AB, Hills N, Shiboski S, et al. Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females. JAMA. 285:2001;2995-3002
5. Nash J, Burke T, Hoskins W. Biologic course of cervical human papillomavirus infection. Obstet Gynecol. 69:1987;160-162
6. Nasiell K, Roger V, Nasiell M. Behavior of mild cervical dysplasia during long-term follow-up. Obstet Gynecol. 67:1986;665-669
7. Syrjanen K, Kataja V, Yliskoski M. Natural history of cervical human papillomavirus lesions does not substantiate the biologic relevance of the Bethesda system. Obstet Gynecol. 79:1992;675-682
8. Wright TJ, Cox J, Massad L, Twiggs L, Wilkinson E. Consensus guidelines for the management of women with cervical cytological abnormalities. JAMA 2002. 287:2001;2120-2129
9. Franco E. Epidemiology of anogenital warts and cancer. Obstet Gynecol Clin North Am. 23:1996;597-623
10. Koutsky LA, Holmes KK, Critchlow CW, et al. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med. 327:1992;1272-1278
11. Holmes KK, Spiegel C, Amsel AR, Eschenbach DA, Chen KC, Totten P. Nonspecific vaginosis. Scand J Infect Dis Supp. 26:1981;110-114
12. Moscicki AB, Palefsky J, Smith G, Shiboski S, Schoolnik G. Variability of human papillomavirus DNA testing in a longitudinal cohort of young women. Obstet Gynecol. 82:1993;578-585
13. Ashley RL, Militoni J, Lee F, Nahmias A, Corey L. Comparison of western blot and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 and 2 in human sera. J Clin Microbiol. 26:1988;662
14. Gravitt P, Peyton CL, Apple RJ, Wheeler CM. Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method. J Clin Microbiol. 26:1998;3020-3027
15. Kurman RJ, Solomon D. The Bethesda system for reporting cervical/vaginal cytologic diagnosis. 1994;Springer-Verlag, New York
16. Joly P, Commenges D, Letenneur L. A penalized likelihood approach for arbitrarily censored and truncated data: application to age-specific incidence of dementia. Biometrics. 54:1998;185-194
17. Bacchetti P, Jewell NP. Nonparametric estimation of the incubation period of AIDS based on a prevalent cohort with unknown infection times. Biometrics. 47:1990;947-960
18. Smith P, Thompson TJ, Jereb JA. A model for interval-censored tuberculosis outbreak data. Stat Med. 16:1997;485-496
19. Mount S, Papillo J. A study of 10,296 pediatric and adolescent Papanicolaou smear diagnoses in northern New England. Pediatrics. 103:1999;539-545
20. Schlecht NF, Platt RW, Duarte-Franco E, et al. Human papillomavirus infection and time to progression and regression of cervical intraepithelial neoplasia. J Natl Cancer Inst. 95:2003;1336-1343
21. Remmink AJ, Walboomers JM, Helmerhorst TJ, et al. The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: natural history up to 36 months. Int J Cancer. 61:1995;306-311
22. Cuzick J, Szarewski A, Terry G, et al. Human papillomavirus testing in primary cervical screening. Lancet. 345:1995;1533-1536
23. Olsen AO, Gjoen K, Sauer T, et al. Human papillomavirus and cervical intraepithelial neoplasia grade II-III: a population-based case-control study. Int J Cancer. 61:1995;312-315
24. de Vet HC, Knipschild PG, Sturmans F. The role of sexual factors in the aetiology of cervical dysplasia. Int J Epidemiol. 22:1993;798-803
25. La Vecchia C, Franceschi S, Decarli A, et al. Sexual factors, venereal diseases, and the risk of intraepithelial and invasive cervical neoplasia. Cancer. 58:1986;935-941
26. Wright V, Riopelle M. Age at beginning of coitus versus chronologic age as a basis for Papanicolaou smear screening: an analysis of 747 cases of preinvasive disease. Am J Obstet Gynecol. 149:1984;824-830
27. Scott M, Nakagawa M, Moscicki AB. Cell-mediated immune response to human papillomavirus infection. Clin Diagn Lab Immunol. 8:2001;209-220
28. Ries LAG, Eisner MP, Kosary CL. SEER Cancer Statis Rev 1973-1999. Bethesda, MD: National Cancer Institute, 2002.